Durata Therapeutics, Inc. Interest Expense, Long-term Debt
Durata Therapeutics, Inc. reported Interest Expense, Long-term Debt of $1.61 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLongTermDebt · last filed 2014-11-07
- Durata Therapeutics, Inc. interest expense, long-term debt for the quarter ending 2014-09-30 was $1.61M, a 147.99% increase year-over-year.
- Durata Therapeutics, Inc. interest expense, long-term debt for the quarter ending 2014-06-30 was $1.04M, a 59.02% increase year-over-year.
- Durata Therapeutics, Inc. interest expense, long-term debt for the quarter ending 2014-03-31 was $895.00K, a 728.70% increase year-over-year.
- Durata Therapeutics, Inc. interest expense, long-term debt for the quarter ending 2013-12-31 was $816.00K.
- Durata Therapeutics, Inc. interest expense, long-term debt for fiscal 2013 was $2.23M.
| Period end | Interest Expense, Long-term Debt 3 month | Interest Expense, Long-term Debt 3 month as first filed | Interest Expense, Long-term Debt 6 month | Interest Expense, Long-term Debt 6 month as first filed | Interest Expense, Long-term Debt 9 month | Interest Expense, Long-term Debt 9 month as first filed | Interest Expense, Long-term Debt 12 month | Interest Expense, Long-term Debt 44 month | Interest Expense, Long-term Debt 47 month | Interest Expense, Long-term Debt 50 month | Interest Expense, Long-term Debt 53 month | Interest Expense, Long-term Debt 56 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $1.61M 10-Q · filed 2014-11-07 | $2.65M derived: sum of 2 quarters · filed 2014-11-07 | $3.54M 10-Q · filed 2014-11-07 | $4.36M derived: sum of 4 quarters · filed 2014-11-07 | ||||||||
| 2014-06-30 | $1.04M 10-Q · filed 2014-08-07 | $1.94M 10-Q · filed 2014-08-07 | $2.75M derived: sum of 3 quarters · filed 2014-08-07 | $3.40M derived: sum of 4 quarters · filed 2014-11-07 | $4.16M 10-Q · filed 2014-08-07 | |||||||
| 2014-03-31 | $895.00K 10-Q · filed 2014-05-08 | $1.71M derived: sum of 2 quarters · filed 2014-05-08 | $2.36M derived: sum of 3 quarters · filed 2014-11-07 | $3.01M derived: sum of 4 quarters · filed 2014-11-07 | $3.12M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.46M derived: sum of 2 quarters · filed 2014-11-07 | $2.12M derived: sum of 3 quarters · filed 2014-11-07 | $2.23M 10-K · filed 2014-03-14 | $2.23M 10-K · filed 2014-03-14 | |||||||
| 2013-09-30 | $648.00K 10-Q · filed 2014-11-07 | $647.71K 10-Q · filed 2013-11-06 | $1.30M derived: sum of 2 quarters · filed 2014-11-07 | $1.41M 10-Q · filed 2014-11-07 | $1.41M 10-Q · filed 2013-11-06 | $1.41M 10-Q · filed 2013-11-06 | ||||||
| 2013-06-30 | $654.00K 10-Q · filed 2014-08-07 | $654.66K 10-Q · filed 2013-08-07 | $762.00K 10-Q · filed 2014-08-07 | $762.69K 10-Q · filed 2013-08-07 | $762.69K 10-Q · filed 2013-08-07 | |||||||
| 2013-03-31 | $108.00K 10-Q · filed 2014-05-08 |